Laboratorios Farmaceuticos Rovi (LTS:0ILL) Margin of Safety % (DCF Dividends Based) : 57.42% (As of Mar. 02, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2025-03-02), Laboratorios Farmaceuticos Rovi's Predictability Rank is 2.5-Stars. Laboratorios Farmaceuticos Rovi's intrinsic value calculated from the Discounted Dividend model is €138.57 and current share price is €53.10. Consequently,

Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 57.42%.

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based) falls into.

Laboratorios Farmaceuticos Rovi Margin of Safety % (DCF Dividends Based) Calculation

Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)	=	(Intrinsic Value: DCF (Dividends Based)	-	Current Price)	/	Intrinsic Value: DCF (Dividends Based)
	=	(124.71	-	53.10)	/	124.71
	=	57.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Laboratorios Farmaceuticos Rovi Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorios Farmaceuticos Rovi SA (LTS:0ILL) » Definitions » Margin of Safety % (DCF Dividends Based)

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK ROVI:Spain 41L:Germany ROVI:Austria

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi Headlines

No Headlines